Search





Search





Markets
/
Stocks
/
lxeo
/

Lexeo Therapeutics Inc

LXEO

Add to Watchlist

4.480USD

-0.180-3.86%

Close 07-27 16:00（ET）Quotes delayed by 15 min

331.89MMarket Cap

LossP/E TTM

Lexeo Therapeutics Inc

4.480

-0.180-3.86%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-27

Previous score

10.00

Change

The current institutional shareholding score of Lexeo Therapeutics Inc is 10.00, ranking 1 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 112.72%, representing a quarter-over-quarter increase of 25.76%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 1.90M shares, representing 2.27% of shares outstanding, with 43.95% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Janus Henderson Investors

5.51M

-9.76%

RA Capital Management, LP

5.00M

Paradigm BioCapital Advisors LP

4.76M

+29.72%

BlackRock Institutional Trust Company, N.A.

4.49M

+124.63%

Vestal Point Capital, LP

4.47M

+37.69%

Frazier Life Sciences Management, L.P.

4.42M

Affinity Asset Advisors LLC

4.35M

+35.95%

Citadel Advisors LLC

3.77M

+1.49%

Avoro Capital Advisors LLC

3.30M